Fluzone Trivalent Northern Hemisphere
Product Images NDC 83703-083

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fluzone Trivalent Northern Hemisphere (NDC 83703-083). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bamboo Us Bidco Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Principal Display Panel (0.5 mL Syringe Label)

Principal Display Panel (0.5 mL Syringe Label)
Label of FLUZONE Influenza Vaccine 2025-2026 Formula by Sanofi Pasteur Inc. The label indicates it is preservative-free, for intramuscular use, single-dose 0.5 mL. The label also includes placeholder information for lot and expiration dates, and displays barcodes and a QR code. The product is prescription only.*
FDA Label Image

Principal Display Panel (0.5 mL Syringe Package)

Principal Display Panel (0.5 mL Syringe Package)
Packaging label for FLUZONE Influenza Vaccine 2025-2026 Formula by Sanofi Pasteur, for intramuscular use in individuals 6 months of age and older. The box contains 10 single-dose prefilled syringes, each with 0.5 mL. Storage instructions and vaccine composition details are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.